Variations in patient-reported outcome (PRO) collection and reporting in novel FDA approved anticancer therapies. Singhal, S., Hall, E., Gabster, B., Dickerson, J., Schapira, L. AMER SOC CLINICAL ONCOLOGY. 2019

View details for DOI 10.1200/JCO.2019.37.15_suppl.e18202

View details for Web of Science ID 000487345802165